Editing
Pediatrics: Renal and Adrenal Oncology
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Angiomyolipoma (AML) === * '''The renal lesions of the TSC include:''' *# '''AML''' *# '''Simple cysts''' *# '''Polycystic kidney disease''' *# '''RCC''' ** '''AML develops in up to 80% of patients with TSC.''' '''Renal cysts occur in up to 30% of patients with TSC.''' ** Mutations of 1 of 2 genes on chromosome 9 (TSC1) and chromosome 16 (TSC2) are found in 85% of TSC patients * '''Management''' ** '''Children with growing lesions can be managed with embolization or partial nephrectomy before they become symptomatic with bleeding.''' *** '''The risk of serious bleeding appears to correlate with a diameter > 4 cm''' ** '''mTOR inhibitors have shown promise as a new type of therapy for reducing the size of TSC-associated AMLs'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information